THE University of NSW has announced the establishment of the Ainsworth Endometriosis Research Institute (AERI), a world-first initiative between members of the philanthropic Ainsworth family and UNSW Sydney that is set to revolutionise endometriosis research, diagnosis, and treatment for millions of people suffering around the world.
Funded by the family to the tune of $50 million over 10 years, the partnership will position Australia as a global leader in women's health and the fight against endometriosis.
It is estimated one in seven Australian women - around 830,000 people - will have endometriosis by age 49, impacting their health, fertility, careers and daily lives, with an estimated economic cost in the region of $8 billion annually.
Endometriosis is a significant global challenge, affecting around 200 million people, and the World Economic Forum named endometriosis as one of the nine diseases most affecting the lives of women, their communities and the global economy.
AERI will adopt a global consortia-based approach to research, bringing together top scientists, clinicians, and philanthropists from around the world - including England, Canada, Denmark, India and the USA - to unlock a continuous pipeline of scientific discoveries.
"The aim is to accelerate breakthroughs in diagnosis and create precision-based treatments," a spokesperson said.
"By focusing on genomic research, biorepositories and advanced testing, AERI will fast-track new understandings of endometriosis, moving beyond current medical limitations."
The above article was sent to subscribers in Pharmacy Daily's issue from 21 May 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 21 May 25
